0001104659-11-018299.txt : 20110401 0001104659-11-018299.hdr.sgml : 20110401 20110401184302 ACCESSION NUMBER: 0001104659-11-018299 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110401 FILED AS OF DATE: 20110401 DATE AS OF CHANGE: 20110401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Helmut CENTRAL INDEX KEY: 0001515616 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35119 FILM NUMBER: 11733055 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANZYME INC CENTRAL INDEX KEY: 0001274644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 631192270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919 313-4760 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 3 1 a3.xml 3 X0203 3 2011-04-01 0 0001274644 TRANZYME INC TZYM 0001515616 Thomas Helmut C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 0 1 0 0 Sr. VP, Research & Preclinical Stock Option (right to buy) 3.78 2018-02-19 Common Stock 35714 D Stock Option (right to buy) 3.78 2018-02-19 Common Stock 14285 D Stock Option (right to buy) 3.78 2018-02-19 Common Stock 14893 D Stock Option (right to buy) 3.78 2018-02-19 Common Stock 14893 D 25% of the shares vested and became exercisable on June 5, 2007, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter, so that the entire option is presently fully vested and exercisable. 25% of the shares vested and became exercisable on January 4, 2008, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter, so that the entire option is presently fully vested and exercisable. 25% of the shares vested and became exercisable on October 26, 2008, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter. 25% of the shares vested and became exercisable on February 1, 2009, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter. Exhibit 24.1 Power of attorney /s/ Richard I. Eisenstadt, attorney-in-fact 2011-04-01 EX-24.1 2 ex-24d1.htm EX-24.1

Exhibit 24.1

 

LIMITED POWER OF ATTORNEY

 

The undersigned hereby constitutes and appoints each of Vipin K. Garg and Richard I. Eisenstadt, and each of them individually, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

 

(1)           Complete and execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director and/or ten percent (10%) shareholder of Tranzyme, Inc., a Delaware corporation (the “Company”) any Form ID and any and all instruments, certificates and documents required to be executed on behalf of the undersigned as an individual or on behalf of the undersigned’s company or partnership, as the case may be, pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or the rules and regulations thereunder;

 

(2)           Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID or instruments, certificates or documents required to be filed pursuant to Sections 13 and 16 of the Exchange Act or the rules or regulations thereunder and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3)           Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by either such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act which is necessary, proper or desirable to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that either such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

 

The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 13 or Section 16 of the Exchange Act or the rules or regulations thereunder.  The undersigned hereby agrees to indemnify the attorney-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorney-in fact.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any instruments, certificates and documents pursuant to Section 13 and 16 of the Exchange Act or the rules or regulations thereunder with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 15, 2011.

 

 

/s/ Helmut Thomas

 

Helmut Thomas